Læknablaðið - 15.04.2010, Page 26

80TB4O1S.TTI
VIÐ PARKINSONS SJÚKDÓMI
Einlyfjameðferð og viðbótarmeðferð
Áhrifaríkt
Einfalt
U
Einu sinni á dag
Heimildir
1. Parkinson Study Croup. A Controlled Trial of Rasagiline in Early Parkinson Disease. The TEMPO Study Arch Neurol 2002- 59-1937-43
SSu ‘o T StUdT f°up' an adjunct ‘° levodopa in patient5 with Parkinson's disease and motor þuctuations (LARCO, Lasting effect in Adiuna theraov with
Rasagitine Civen Once daily, study): a randomised, double-blind, parallel-group trial. Lancet 2005- 365- 947-54 ° P^
3' aotel: 2SIld248°UP'A Rand°miZed Plaeeho-Contr°iied Trial of Rasagiline in Levodopa-Treated Pa.ients With Parkinson Disease and Mo.or FIuctuations.The PRESTO Study.Arch Neurot
Sérlyfjatexti á bls. 303